Teveten HCT is a brand name of eprosartan/hydrochlorothiazide, approved by the FDA in the following formulation(s):
TEVETEN HCT (eprosartan mesylate; hydrochlorothiazide - tablet; oral)
Manufacturer: ABBOTT
Approval date: November 1, 2001
Strength(s): 600MG;12.5MG, 600MG;25MG [RLD]
Has a generic version of Teveten HCT been approved?
No. There is currently no therapeutically equivalent version of Teveten HCT available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Teveten HCT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Angiotensin II receptor blocking compositions
Patent 5,656,650
Issued: August 12, 1997
Inventor(s): Weinstock; Joseph
Assignee(s): SmithKline Beecham Corp.
This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a .beta.-adrenoceptor blocker, a renin inhibitor, or an angiotensin converting enzyme inhibitor and a method of treating hypertension.Patent expiration dates:
- August 12, 2014✓
- August 12, 2014
See also...
- Teveten HCT Consumer Information (Wolters Kluwer)
- Teveten HCT Consumer Information (Cerner Multum)
- Teveten HCT Advanced Consumer Information (Micromedex)
- Eprosartan/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
- Hydrochlorothiazide and eprosartan Consumer Information (Cerner Multum)
- Eprosartan and hydrochlorothiazide Advanced Consumer Information (Micromedex)
No comments:
Post a Comment